Emergent Biosolutions reported $363.7M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Akebia Therapeutics AKBA:US $ 103.64M 28.61M
ALKERMES ALKS:US 313.8M 14.5M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amarin AMRN:US 155.11M 9.4M
Ani Pharmaceuticals ANIP:US $ 55.62M 8.56M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Chimerix CMRX:US 18.71M 501K
Coherus Biosciences CHRS:US $ 115.29M 3.48M
Emergent Biosolutions EBS:US $ 363.7M 19.3M
Exact Sciences EXAS:US $ 618.4M 11.92M
Exelixis EXEL:US $ 276.8M 14.63M
Flexion Therapeutics FLXN:US $ 44.98M 73K
Glaxosmithkline GSK:US 7.14B 722M
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Immunogen IMGN:US $ 43.44M 873K
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Ironwood Pharmaceuticals IRWD:US $ 38.58M 0.36M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Lexicon Pharmaceuticals LXRX:US 22.98M 4.79M
Lonza Group LONN:SW 2.22B 1.07B
Merk MRK:US $ 8328M 1460M
Moderna Inc MRNA:US 1.41B 119M
Myriad Genetics MYGN:US $ 247.2M 37M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Opko Health OPK:US $ 347.99M 88.85M
Pacira Pharmaceuticals PCRX:US $ 96.29M 4.46M
Pfizer PFE:US $ 16447M 3384M
Ptc Therapeutics PTCT:US $ 231.82M 16.65M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Seattle Genetics SGEN:US $ 722.02M 243.94M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M
United Therapeutics UTHR:US $ 216M 10.6M
Vanda Pharmaceuticals VNDA:US $ 59.28M 3.75M
Xoma XOMA:US $ 4.28M 20K